CME: Postoperative Cardiac Issues After Arthroplasty

CME: Postoperative Cardiac Issues After Arthroplasty
Author Information (click to view)

Andrew J. Schoenfeld, MD, MSc

Associate Orthopaedic Surgeon
Brigham and Women’s Hospital
Instructor, Orthopaedic Surgery
Harvard Medical School

Andrew J. Schoenfeld, MD, MSc, has indicated to Physician’s Weekly that he has or has had no financial interests to report

Figure 1 (click to view)
Figure 2 (click to view)
Target Audience (click to view)

This activity is designed to meet the needs of physicians.

Learning Objectives(click to view)

Upon completion of the educational activity, participants should be able to:

 

  1. Discuss the findings of a study that examined the rates, risk factors, and time of occurrence for cardiac complications at 30 days following total knee and hip arthroplasty.

Method of Participation(click to view)

Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.akhcme.com/pwDec4.  You must participate in the entire activity to receive credit.  If you have questions about this CME/CE activity, please contact AKH Inc. at dcotterman@akhcme.com.

Credit Available(click to view)

AKH

CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

 

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support(click to view)

There is no commercial support for this activity.

Disclosures(click to view)

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use & Investigational Product(click to view)

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer(click to view)

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Faculty & Credentials(click to view)

FACULTY DISCLOSURES

Keith D’Oria – Editorial Director
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
Andrew J. Schoenfeld, MD, MSc
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
 
 AKH and PHYSICIAN WEEKLY’S STAFF/REVIEWERS

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH planners and reviewers have no relevant financial relationships to disclose.

+


Andrew J. Schoenfeld, MD, MSc (click to view)

Andrew J. Schoenfeld, MD, MSc

Associate Orthopaedic Surgeon
Brigham and Women’s Hospital
Instructor, Orthopaedic Surgery
Harvard Medical School

Andrew J. Schoenfeld, MD, MSc, has indicated to Physician’s Weekly that he has or has had no financial interests to report

+
+
Several significant risk factors for developing postoperative cardiac complications after total knee and hip arthroplasty have been identified. For high-risk patients, clinicians should pay special attention to preoperative cardiology evaluations and careful perioperative monitoring.
Share on FacebookTweet about this on TwitterShare on LinkedIn

Cardiac events are major postoperative complications that can occur in patients undergoing total knee arthroplasty and total hip arthroplasty. Some studies have shown that serious cardiac complications, including myocardial infarction and cardiac arrest, account for 7% to 20% of all major systemic complications following these procedures. “Hospitals are increasingly implementing performance-based outcome metrics and penalizing those with high readmission rates after elective procedures like these,” explains Andrew J. Schoenfeld, MD, MSc. “As such, it’s important to look at risk factors that may play a role in the development of cardiac complications after total knee arthroplasty and total hip arthroplasty.”

Little is known about how patient-based risk factors affect risks for postoperative cardiac complications among total knee and hip arthroplasty recipients. Understanding these risk factors can help clinicians counsel their patients before their surgery. By identifying high-risk patients, targeted interventions can be developed to improve patient outcomes and reduce the incidence of unplanned hospital readmissions and morbidity after total knee and hip arthroplasty.

A Detailed Investigation

Previous studies on adverse postoperative cardiac outcomes after arthroplasty may be limited because their samples usually come from individual centers and the surgeons performing these procedures may have extensive experience. In the Journal of Bone & Joint Surgery, Dr. Schoenfeld and colleagues had a study published that examined the rates, risk factors, and time of occurrence for cardiac complications at 30 days following total knee and hip arthroplasty.

“Our study sample included more than 46,000 patients undergoing either primary unilateral total knee arthroplasty or total hip arthroplasty at numerous medical centers in the United States participating in the American College of Surgeons’ National Surgical Quality Improvement Program (ACS NSQIP),” says Dr. Schoenfeld. For the study, the ACS NSQIP data set from 2006 to 2011 was used to identify all total knee arthroplasties and total hip arthroplasties. Patients were designated as having a history of heart disease if they had a new diagnosis or exacerbation of chronic congestive heart failure or a history of angina within 30 days of surgery, a history of myocardial infarction (MI) within 6 months, and/or any PCI or other major cardiac surgeries at any time.

Overall, the cardiac complication rate was 0.33% at 30 days after patients were treated with total knee or hip arthroplasty (Table 1). No significant differences were observed between arthroplasty groups regarding the occurrence of MI, cardiac arrest requiring cardiopulmonary resuscitation, or the development of a major adverse cardiac event. The 30-day all-cause mortality rates were 0.18% for total knee arthroplasty recipients and 0.35% for total hip arthroplasty recipients. However, the total hip arthroplasty group had a significantly higher 30-day odds ratio of mortality when compared with the total knee arthroplasty group (odds ratio, 1.87).

Risk Factors Identified

The study also revealed several significant independent predictors for major cardiac complications in patients undergoing these procedures (Table 2). “For both the total knee arthroplasty group and the total hip arthroplasty groups, significant risk factors included patients being 80 years of age and older, those with hypertension requiring medication, and those with a history of heart disease,” Dr. Schoenfeld says. A history of transient ischemic attack or cerebrovascular accident was identified as another risk factor for patients undergoing total hip arthroplasty.

Among patients who underwent these arthroplasty procedures and suffered a cardiac complication, 79% of these complications occurred within 7 days of their surgery. About 63% of total knee arthroplasty patients and 77% of total hip arthroplasty patients who had an adverse cardiac event experienced it within 3 days of their procedure. This finding supports the practice of careful patient observation and delaying discharge until at least 3 days after surgery in order to capture possible cardiac events in the hospital.

Put the Data to Work

The number of Americans undergoing primary total knee and hip arthroplasty are projected to continue to climb over the next decade, making it increasingly important to consider the effects of adverse cardiac complications following these surgeries. “Ideally, we want data from our study to be used to develop and validate a simple risk score that is quick and easy to use, applicable to everyone, and meaningful to surgeons,” Dr. Schoenfeld says.

The study noted that patients with one or more of the risk factors identified in the analysis and who are planning to undergo total knee or hip arthroplasty should be considered for preoperative cardiology evaluations and co-managed with cardiology consults during the perioperative period. “With a better understanding of the implications of these risk factors,” adds Dr. Schoenfeld, “we can have more informed preoperative conversations with patients and discuss efforts to reduce risks before surgery.”

 

Readings & Resources (click to view)

Belmont Jr PJ, Goodman GP, Kusnezov NA, et al. Postoperative myocardial infarction and cardiac arrest following primary total knee and hip arthroplasty: rates, risk factors, and time of occurrence. J Bone Joint Surg Am, 2014;96: 2025-2031. Available at: http://jbjs.org/content/96/24/2025.

Basilico FC, Sweeney G, Losina E, et al. Risk factors for cardiovascular complications following total joint replacement surgery. Arthritis Rheum. 2008;58:1915-1920.

Dy CJ, Wilkinson JD, Tamariz L, Scully SP. Influence of preoperative cardiovascular risk factor clusters on complications of total joint arthroplasty. Am J Orthop. 2011;40:560-565.

Gandhi R, Petruccelli D, Devereaux PJ, Adili A, Hubmann M, de Beer J. Incidence and timing of myocardial infarction after total joint arthroplasty. J Arthroplasty. 2006;21:874-877.

Lalmohamed A, Vestergaard P, Klop C, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med. 2012;172:1229-1235.

Submit a Comment

Your email address will not be published. Required fields are marked *

12 − three =